9INX
Crystal structure of DAPK1 in complex with compound 10
This is a non-PDB format compatible entry.
Summary for 9INX
| Entry DOI | 10.2210/pdb9inx/pdb |
| Descriptor | Death-associated protein kinase 1, (~{E})-1-[2,4-bis(oxidanyl)phenyl]-3-(3-bromanyl-4-oxidanyl-phenyl)prop-2-en-1-one, SULFATE ION, ... (4 entities in total) |
| Functional Keywords | dapk1, kinase, inhibitor, isoliquiritigenin, transferase |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 34227.61 |
| Authors | |
| Primary citation | Yokoyama, T.,Hisatomi, K.,Oshima, S.,Tanaka, I.,Okada, T.,Toyooka, N. Discovery and optimization of isoliquiritigenin as a death-associated protein kinase 1 inhibitor. Eur.J.Med.Chem., 279:116836-116836, 2024 Cited by PubMed Abstract: Death-associated protein kinase 1 (DAPK1) is a phosphotransferase in the serine/threonine kinase family. Inhibiting DAPK1 is expected to be beneficial in treating Alzheimer's disease and protecting neuronal cells during cerebral ischemia. In this study, we demonstrated that the natural chalcone isoliquiritigenin inhibits DAPK1 in an ATP-competitive manner, and we synthesized halogen derivatives to amplify the inhibitory effect. Among the compounds tested, the chlorine, bromine, and iodine derivatives exhibited high DAPK1 inhibitory activity and binding affinity. Crystal structure analysis revealed that this improvement is attributable to the halogen atoms fitting well into the hydrophobic pocket formed by I77, L93, and I160. In particular, the chlorine derivative showed a significant enthalpic contribution to the interaction with DAPK1, suggesting its potential as a primary compound for new DAPK1 inhibitors. PubMed: 39243455DOI: 10.1016/j.ejmech.2024.116836 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.72 Å) |
Structure validation
Download full validation report
